Reading time: 5 min Author Published on Updated on Weight loss Get expert guidance and a personalized care plan designed around you
P = 0.0006), and dulaglutide in REWIND trial (HR 0.88
L-RZ, W-JN, MC and H-PL drafted the work or revised it critically for important intellectual content
Study: Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation
There are serious risks to pregnancy when on these drugs, and women need to be monitored very closely, especially if they are trying to get pregnant, added Grifo, going on to explain that a medical endocrinologist who specializes in weight loss, diabetes, and endocrine issues would be the best choice for supervising your case